Ask AI
Amrita Krishnan

Amrita Krishnan, MD, FACP

Director, Judy and Bernard Center for Myeloma, City of Hope
Nason Hollingsworth Family Chair Myeloma
Executive Director, Hematology, City of Hope Orange County
Professor Hematology/HCT
Irvine, California 

Explore Activities by Amrita Krishnan

Title
Format
Credit Type
Credits
Expert Insights on the Most Practice-Changing Evidence for CAR T-Cell Therapy Across Hematologic Malignancies

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Practice-Changing Evidence for CAR T-Cell Therapy Across Hematologic Malignancies

Content Format:

Slideset

Credit Type:

--

Credits:

--
CELMoDs in Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Experts Discuss CELMoDs in Myeloma

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.75
CELMoDs in Myeloma—What’s Here, What’s Next, and What’s on the Horizon

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.25
CELMoDs in Myeloma—What’s Here, What’s Next, and What’s on the Horizon

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.25
Use of MRD in Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Novel Approaches to Protein Degradation Pathways in Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Anticipating Advances in CAR T-Cell Therapies in Myeloma: Expert Discussion and Case Exploration

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Overview of CAR T-Cell Therapy in Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Managing Acute and Long-term Toxicities With CAR T-Cell Products

Content Format:

Slideset

Credit Type:

--

Credits:

--
ExpressPoints: Anticipating Advances in CAR T-Cell Therapies in Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--